Analgesic nephropathy prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD [2]

Overview

It has been suggested that in clinical practice, non-opioid analgesics, when possible, should be avoided for long-term use due to their nephrotoxicity.

Prevention

It has been suggested that in clinical practice, non-opioid analgesics, when possible, should be avoided for long-term use due to their nephrotoxicity.^[1]

References

↑ Yaxley J (2016). “Common analgesic agents and their role in analgesic nephropathy: A commentary of the evidence”. Int J Risk Saf Med. 28 (4): 189–196. doi:10.3233/JRS-170735. PMID 28582877.

Template:WH Template:WS

[pmid28582877-1] Yaxley J (2016). “Common analgesic agents and their role in analgesic nephropathy: A commentary of the evidence”. Int J Risk Saf Med. 28 (4): 189–196. doi:10.3233/JRS-170735. PMID 28582877.

[1]

Analgesic nephropathy prevention

Overview

Prevention

References

Looking for the patient version?